Science Explorer Interactive view Map
Company · Espoo · Finland

Medtentia (Finland)

medtentia.comROR OpenAlex
Research works
0
fractional, all time
Citations
1
3.0 per fractional work
Top-10% rate
0.0%
record average 16.5%

Not ranked overall: Medtentia (Finland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Medtentia (Finland) publish most on?

By volume in 2022–2025: Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies and HER2/EGFR in Cancer Research.

Advanced Breast Cancer T…0Advanced Breast Cancer Therapies: 0 fractional worksBreast Cancer Treatment …0Breast Cancer Treatment Studies: 0 fractional worksHER2/EGFR in Cancer Rese…0HER2/EGFR in Cancer Research: 0 fractional works
Pulmonary and Respiratory MedicineCancer ResearchOncology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  2. 2 Breast Cancer Treatment Studies Cancer Research 0 works
  3. 3 HER2/EGFR in Cancer Research Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

with international co-authors61.5%domestic only38.5%

World: 19% is written across borders.

Other research institutions in Espoo

All research institutions in Espoo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.